| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/12/2001 | WO2001025252A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | WO2001025242A1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 04/12/2001 | WO2001025239A2 Oxazinoquinolones useful for the treatment of viral infections |
| 04/12/2001 | WO2001025238A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 04/12/2001 | WO2001025237A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | WO2001025209A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/12/2001 | WO2001025208A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 04/12/2001 | WO2001025207A1 Novel nicotinonitrile compounds |
| 04/12/2001 | WO2001025204A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | WO2001025190A1 Novel diarylamide derivatives and use thereof as medicines |
| 04/12/2001 | WO2001025188A1 Novel carbamates and ureas |
| 04/12/2001 | WO2001025186A1 Novel ltb4 antagonist, method for the production thereof and its use as a medicament |
| 04/12/2001 | WO2001024842A2 Hybrid matrices and hybrid matrix mixtures |
| 04/12/2001 | WO2001024824A1 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 04/12/2001 | WO2001024823A1 Cd40 antagonist for treating psoriasis |
| 04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | WO2001024814A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/12/2001 | WO2001024806A1 Apple tree branch extracts for dermatological and cosmetic use and method for preparing same |
| 04/12/2001 | WO2001024804A2 Method for preparing a composition by mother-of-pearl extraction, and use thereof in cosmetics and dermatology |
| 04/12/2001 | WO2001024796A1 1,2,4-triazole derivatives, composition, process of making and methods of use |
| 04/12/2001 | WO2001024787A1 Use of xanthophylls, astaxanthin e.g., for treatment of autoimmune diseases, chronic viral and intracellular bacterial infections |
| 04/12/2001 | WO2001024764A2 Cell targeting compositions and methods of using the same |
| 04/12/2001 | WO2001024763A2 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 04/12/2001 | WO2000069426A3 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders |
| 04/12/2001 | WO2000061755A3 Secreted human proteins |
| 04/12/2001 | WO2000056304A3 Anti-inflammatory uses of manzamines |
| 04/12/2001 | WO2000031134A8 Regulation of hair follicle morphogenesis based on beta-catenin |
| 04/12/2001 | WO2000004891A3 Anti-ulcer composition |
| 04/12/2001 | DE19952190A1 Use of amylum for healing chronic weeping wounds, especially leg ulcers |
| 04/12/2001 | DE19948428A1 Neuer LTB¶4¶-Antagonist, Verfahren zu dessen Herstellung und dessen Verwendung als Arzneimittel New LTB¶4¶ antagonist, process for its preparation and its use as a medicament |
| 04/12/2001 | CA2699662A1 Rhodamine derivatives for photodynamic diagnosis, prevention and treatment of immunologic disorders |
| 04/12/2001 | CA2388785A1 Use of xanthophylls, astaxanthin e.g., for treatment of autoimmune diseases, chronic viral and intracellular bacterial infections |
| 04/12/2001 | CA2388487A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | CA2386540A1 Novel carbamates and ureas |
| 04/12/2001 | CA2386377A1 Cell targeting compositions and methods of using the same |
| 04/12/2001 | CA2386239A1 Methods for identifying rna binding compounds |
| 04/12/2001 | CA2386228A1 Stabilized liquid pharmaceutical compositions comprising tissue factor pathway inhibitor (tfpi) polypeptides |
| 04/12/2001 | CA2386071A1 Apple tree branch extracts for dermatological and cosmetic use and method for preparing same |
| 04/12/2001 | CA2385972A1 Novel diarylamide derivatives and use thereof as medicines |
| 04/12/2001 | CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | CA2385528A1 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 04/12/2001 | CA2385251A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | CA2385244A1 Novel nicotinonitrile compounds |
| 04/12/2001 | CA2385210A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | CA2385127A1 Novel hepatoma-derived growth factor-like proteins, polynulceotides encoding them and methods of use |
| 04/12/2001 | CA2385045A1 Ifn-alpha homologues |
| 04/12/2001 | CA2382859A1 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | CA2382691A1 Oxazinoquinolones useful for the treatment of viral infections |
| 04/12/2001 | CA2379971A1 Hybrid matrices and hybrid matrix mixtures |
| 04/12/2001 | CA2351075A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/11/2001 | EP1090989A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090926A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090925A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090639A2 Pharmaceutical composition containing a progestational corticoid and a selective estrogen receptor modulator |
| 04/11/2001 | EP1090637A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/11/2001 | EP1090630A1 Skin normalizing agents |
| 04/11/2001 | EP1090629A1 Aescin and dextran sulfate association |
| 04/11/2001 | EP1090130A1 Protein c derivatives |
| 04/11/2001 | EP1090104A1 Methods of expanding and selecting disease associated t-cells |
| 04/11/2001 | EP1090014A1 Arylsulfonanilide phosphates |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089872A1 Multi-action particle for structuring biological media |
| 04/11/2001 | EP1089753A2 Use of a dipeptide for stimulating repair processes |
| 04/11/2001 | EP1089752A1 Alpha-keto oxadiazoles as serine protease inhibitors |
| 04/11/2001 | EP1089723A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 04/11/2001 | EP0984963B1 Novel compounds |
| 04/11/2001 | EP0800585B1 Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them |
| 04/11/2001 | CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 04/11/2001 | CN1291107A Skin cave compositions |
| 04/11/2001 | CN1291094A Bicyclic pyrrole derivatives as MCP-1 inhibitor |
| 04/11/2001 | CN1290549A Chinese medicine preparation for hair growth |
| 04/11/2001 | CN1290545A Composite trichogen |
| 04/11/2001 | CN1290544A Combined medicine for curing alopecia areata |
| 04/11/2001 | CN1290542A Tincture for curing skin diseases |
| 04/11/2001 | CN1290535A Medicinal liquid for curing scald and burn |
| 04/11/2001 | CN1290529A Fast-acting antiphlogistic and itch-stopping cream |
| 04/11/2001 | CN1290527A Skin-care cream |
| 04/11/2001 | CN1290522A Skin-care cosmetics containing peroxide |
| 04/11/2001 | CN1064362C Pyrimido [5,4-D] pyrimidines, medicine containing these compounds, their use and process for their production |
| 04/11/2001 | CN1064264C Application of selenium-rich glossy ganoderma in medicine for treating psoriasis |
| 04/11/2001 | CN1064259C Medicine for curing dermatosis |
| 04/11/2001 | CN1064251C Liquid medicine for curing burn |
| 04/11/2001 | CN1064250C Jieyangting ointment for scabies |
| 04/11/2001 | CN1064244C application of Chinese herb Job's tears seed extract in preparing medicine for curing erythematous and squamous keratosis and erythuria |
| 04/11/2001 | CN1064237C Scar inhibitor and its compounding process |
| 04/10/2001 | US6215002 Cyclization, deblocking, deprotection, sulfonation, condensation, amidation; antiinflammatory agents; respiratory system disorders |
| 04/10/2001 | US6214889 Liquid or gel composition comprising one or more of potassium formate, sodium formate, calcium formate and cesium formate |
| 04/10/2001 | US6214880 Lowering plasma cholesterol levels and inhibiting abnormal cell proliferation with said compound; treatment of cancer, psoriasis, vascular restenosis, infections, atherosclerosis and hypercholesterolemia |
| 04/10/2001 | US6214878 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 04/10/2001 | US6214870 Antiarthritic agents; anticancer agents |
| 04/10/2001 | US6214866 Composition comprising mupirocin and chlorhexidine |
| 04/10/2001 | US6214852 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 04/10/2001 | US6214844 Substituted imidazole compounds |
| 04/10/2001 | US6214839 Substituted 6-alkylphenanthridines |
| 04/10/2001 | US6214817 Nitrogen macrocycle complexes with manganese and iron |
| 04/10/2001 | US6214808 Hemostatic agent |
| 04/10/2001 | US6214795 Polypetides with amino acid sequences |
| 04/10/2001 | US6214360 Pharmaceutical composition |
| 04/10/2001 | US6214327 Antibacterial composition |
| 04/10/2001 | US6214325 Improving smoothness, combing and/or disentangling of hair |